---

A short review on impact of Covid-19 in diabetic chronic kidney disease patients

Full Text PDF Share on Facebook Share on Twitter

---

Review Article

Author Details : Akashkumar N Singh*

Volume : 5, Issue : 1, Year : 2022

Article Page : 7-10

https://doi.org/10.18231/j.ijnmhs.2022.002

Suggest article by email

Get Permission

Abstract

Patients with diabetes and chronic kidney disease including end-stage kidney disease, and kidney transplant recipients are at increased risk of severe COVID-19 infection, hospitalization and premature death. Both diabetes and CKD exert synergistic effect on increasing the patient’s susceptibility towards risk of COVID-19 infection. The Global Burden of Disease collaboration (GBD) and WHO have declared CKD and diabetes as the most prevalent risk factors for severe COVID-19. Hence, management should focus on both infection prevention and treatment. Several studies and adequate evidence from literature is available on the impact of COVID-19 disease on diabetes alone or CKD alone. However, many data is not available on COVID-19 disease impact on diabetic CKD patients. This short review article focuses on understanding the impact of COVID-19 on diabetic CKD patients and other aspects such as pathophysiology, epidemiology, prevention and management of diabetic CKD patients with COVID-19 infection.

Keywords: COVID-19, Diabetes and Chronic Kidney Disease

How to cite : Singh A N, A short review on impact of Covid-19 in diabetic chronic kidney disease patients. J Nutr Metab Health Sci 2022;5(1):7-10

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.